FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely therapeutics, cardiology and rheumatology, and can be used for predicting the development and non-clinical diagnostics of the left ventricular systolic dysfunction in patients with ankylosing spondylitis, including determining the duration of the disease, the stage of sacroiliitis, the presence or absence of extra-articular manifestations of ankylosing spondylitis, after which the probability p of the occurrence of an elevated level of MMP-9 is determined by a formula. At the obtained p values >0.5 a blood test is performed to determine the level of MMP-9, if it is above the norm (150 ng/ml), the patient shows a high probability of developing the left ventricular systolic dysfunction in the coming years and needs to have the function of the myocardium checked regularly and carefully.
EFFECT: invention provides an effective method for predicting the development of the systolic dysfunction in individuals suffering from ankylosing spondylitis in the absence of a clinical picture of chronic heart failure.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF RISK OF UNFAVOURABLE CARDIOVASCULAR EVENTS IN PATIENTS SUFFERING ISCHEMIC HEART DISEASE WITH ISCHEMIC AND/OR POSTINFARCTION MYOCARDIAL DYSFUNCTION ACCOMPANYING CHRONIC CARDIAL INSUFFICIENCY | 2014 |
|
RU2568577C1 |
METHOD FOR DETERMINING INDICATIONS TO SURGICAL TREATMENT OF CARDIAC ISCHEMIA PATIENTS SURVIVED AFTER MYOCARDIAL INFARCTION | 2004 |
|
RU2269934C1 |
METHOD FOR PRODUCING ULTRASONIC ANTRACYCLINE- INDUCED CARDIOTOXICITY EVALUATION IN ONCOLOGICAL PATIENTS | 2002 |
|
RU2225166C2 |
METHOD OF DETERMINING MYOCARDIAL FAILURE | 2010 |
|
RU2460463C2 |
METHOD FOR ASSESSING LEFT VENTRICULAR MYOCARDIAL DEFORMATION IN SMOKERS WITH EARLY STAGES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE OF LIGHT DEGREE AND ARTERIAL HYPERTENSION OF I STAGE | 2020 |
|
RU2743245C1 |
METHOD FOR EVALUATING FUNCTIONAL STATE OF LEFT VENTRICLE MYOCARDIUM BY DETERMINING CARDIAC MUSCLE DYSFUNCTION INDEX | 2000 |
|
RU2182459C2 |
METHOD OF DETERMINING VENOUS STASIS ON SYSTEMIC CIRCULATION IN PATIENTS WITH CHRONIC HEART FAILURE | 2010 |
|
RU2449289C2 |
METHOD FOR PHENOTYPING CHRONIC HEART FAILURE BASED ON METABOLOMIC PROFILING | 2024 |
|
RU2841230C1 |
METHOD OF DETECTING RISK GROUP OF DIASTOLIC AORTIC VENTRICLE DYSFUNCTION IN PATIENTS SUFFERING FROM CORONARY HEART DISEASE | 2007 |
|
RU2356499C1 |
METHOD FOR PREDICTING CARDIAC INSUFFICIENCY IN CARDIAC ISCHEMIA PATIENTS IN POSTINFARCTION PERIOD | 2004 |
|
RU2269922C1 |
Authors
Dates
2023-02-28—Published
2022-07-28—Filed